Tramiprosate
Navigation Links
Tramiprosate in Medical News
...it the Web Site at www.bellushealth.com .
(1) S. Gauthier, P. S. Aisen, S. H. Ferris, D. Saumier, A. Duong,
D. Haine, et al. (2009). Effect of tramiprosate in Patients with
Mild-to-Moderate Alzheimer's Disease: Exploratory Analyses of the MRI
Sub-group of the Alphase Study. Journal of Nutrition, Healt...
...dge and the experience it has gained in developing tramiprosate (ALZHEMED(TM)) for the treatment of Alzheimer's di...ize and accelerate the development of a prodrug of tramiprosate (ALZHEMED(TM)), a new chemical entity (NCE), for t...ation of the European Phase III clinical trial for tramiprosate (ALZHEMED(TM)). The Company completed fiscal 2007 ...
...rt the North American Phase III clinical trial for tramiprosate (ALZHEMED(TM)), the open-label extension of the ep...year. The Company announced the termination of the tramiprosate (ALZHEMED(TM); homotaurine) pharmaceutical drug de... the advancement of its next generation prodrug of tramiprosate (ALZHEMED(TM)) into preclinical development for th...
BELLUS Health Inc. Announces $12 Million Rights Offering To Common Shareholders
...or the treatment of Type II diabetes and certain features of metabolic syndrome, approximately $2 million for the development of NRM8499, a prodrug of tramiprosate for the treatment of Alzheimer's disease, and approximately $1.4 million for other research and development (R&D) projects. The remainder will be ...BELLUS Health reports results for first quarter of fiscal 2009
... to a reduction in the research and development of tramiprosate (ALZHEMED(TM); homotaurine) for the treatment of A...mpany's decision in November 2007 to terminate the tramiprosate (ALZHEMED(TM)) pharmaceutical drug development pro...represent the sales of VIVIMIND(TM) (also known as tramiprosate and homotaurine), the Company's first natural heal...BELLUS Health reports results for the fourth quarter of 2008
...t the initial sales of VIVIMIND(TM) (also known as tramiprosate and homotaurine), the Company's first natural heal...xpenses incurred in relation to the development of tramiprosate (ALZHEMED(TM); homotaurine) for the treatment of A...mpany's decision in November 2007 to terminate the tramiprosate (ALZHEMED(TM)) pharmaceutical drug development pro...BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update
...xpenses incurred in relation to the development of tramiprosate (ALZHEMED(TM); homotaurine) for the treatment of A...mpany's decision in November 2007 to terminate the tramiprosate (ALZHEMED(TM)) pharmaceutical drug development pro...xpenses incurred in relation to the development of tramiprosate (ALZHEMED(TM); homotaurine) for the treatment of A...BELLUS HEALTH reports results for first quarter of fiscal 2008
...xpenses incurred in relation to the development of tramiprosate (ALZHEMED(TM); homotaurine) for the treatment of A...mpany's decision in November 2007 to terminate the tramiprosate (ALZHEMED(TM)) pharmaceutical drug development pro...dge and the experience it has gained in developing tramiprosate (ALZHEMED(TM)) for the treatment of AD, BELLUS Hea......dge and the experience it has gained in developing tramiprosate (ALZHEMED(TM)) for the treatment of Alzheimer's di...ize and accelerate the development of a prodrug of tramiprosate (ALZHEMED(TM)), a new chemical entity (NCE), for t...ation of the European Phase III clinical trial for tramiprosate (ALZHEMED(TM)). The Company completed fiscal 2007 ...
...rt the North American Phase III clinical trial for tramiprosate (ALZHEMED(TM)), the open-label extension of the ep...year. The Company announced the termination of the tramiprosate (ALZHEMED(TM); homotaurine) pharmaceutical drug de... the advancement of its next generation prodrug of tramiprosate (ALZHEMED(TM)) into preclinical development for th...
Neurochem reports results for third quarter of fiscal 2007
...afety, efficacy and disease modification effect of tramiprosate (ALZHEMED(TM)) for the treatment of AD. The North ...ive data showing numerical differences in favor of tramiprosate (ALZHEMED(TM)), did not demonstrate a statisticall...onclusions with respect to the treatment effect of tramiprosate (ALZHEMED(TM)). Neurochem has established a Specia...Tramiprosate in Medical Technology
WASHINGTON, DC, June 11, 2007 /PRNewswire-FirstCall/ - Paul S.
Aisen, M.D., Professor of Neurology and Medicine at Georgetown
University Medical Center, and principal investigator in the United
States of Neurochem Inc.'s North American Phase III clinical trial
for tramiprosate (ALZHEMED(TM)) will ...
Tramiprosate in Biological News
Tramiprosate (Alzhemed? preclinical results published in Neurobiology of Aging
...of a publication on the preclinical development of tramiprosate (3-amino-1-propanesulfonic acid; Alzhemed?, includ...acy results in a mouse model of brain amyloidosis. tramiprosate (Alzhemed? represents a potential new class of the...oid binding and neuroprotective characteristics of tramiprosate (Alzhemed? and provide evidence for the potential ...Other TagsUBMOther Contentstraptraptraptraptraptraptraptransvaginaltransvaginalattacksattacksattacksattacksattacksattacksattacksischemicischemicischemicischemicischemicischemicrejectionrejectionrejectionrejectionrejectionrejectionrejectiontransplanttransplanttransplanttransplanttransplanttransplanttransplantresectionresectionresectionresection
IntracanicularFlexPlugPrevailCINCHBioprosthesisBioprosthesesVenogramMicroscanABDv2UBMBioMicroscopeUltraScanKatzenChayet
(Date:11/27/2009)...e-USNewswire/ -- Preventing disease is the goal of...year, new vaccines are being added to assist in di...ty for the same period of time? And, if not, when ...nity strong? ,, In this month,s issue of Pedi...iatrics, Michael Pichichero MD, Director of the Ro...
(Date:11/27/2009)...conomic burdens, study predicts , , FRID...le with diabetes in the United States is expected ...icts. , That would bring the total by 2034 to a... 23.7 million today. , , At the same time, the c...the study also warns, rising from an estimated $11...
(Date:11/27/2009)... anatomy education apps from Modality and Lippinco...earning opportunities for iPhone and iPod touch ,...er 27, 2009 -- Modality, Inc. and Lippincott Wil...luwer Health, today announced the availability of ... Clemente’s Anatomy, Rohen’s Photograp...
(Date:11/26/2009)... strains or worse , , THURSDAY, Nov. 26 ...h stuffing your turkey full to bursting, but you m...ase as you pack for holiday trips. , More than ...l emergency rooms, doctors, offices, clinics and o...es, such as muscle strains, pulls and tears, accor...
(Date:11/26/2009)... announces a highly effective and unconventional b...make an economic recovery. , ...type of challenge that could send ailing holiday s... Benton, business growth expert and author of the ... Rfactor Intensive . “Fear is one of the b...
Breaking Medicine News(10 mins):Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Pharmacist Injects Cure for Ailing Businesses 2[0] Why Some Vaccines May Require A Booster[0] Diabetes Cases Expected to Double in 25 Years[0] Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store[2] Pack Right for the Holidays to Avoid the ER[1] Pharmacist Injects Cure for Ailing Businesses
(Date:11/24/2009)...a remarkable class of ring-shaped protein motors h... Berkeley National Laboratory (Berkeley Lab) using...ne at the Advanced Light Source (ALS). These prote...d replication, and are vital to the survival of al...such as the human papillomavirus, which has been l...
(Date:11/24/2009)... is a matter of debate. A high-profile study a few...nt of their carbon from trees and leaves, evidence... aquatic ecosystems. , But new research from the... to be true. Algae provide a much richer diet for ... published this week in the Proceedings of the Na...
(Date:11/23/2009)...nity-associated strain of the deadly superbug MRSA...mmon antibioticsposes a far greater health threat ...ospitals, according to a study in the December iss... threat is easily picked up in fitness centers, sc...he overall burden of MRSA within hospitals, the re...
Breaking Biology News(10 mins):Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3New study finds MRSA on the rise in hospital outpatients 2Sarnova Acquires Metropolitan Medical to Expand Portfolio of Specialty Health Care Products 5980 1Sarnova Acquires Metropolitan Medical to Expand Portfolio of Specialty Health Care Products 5980 2Sarnova Acquires Metropolitan Medical to Expand Portfolio of Specialty Health Care Products 5980 3Dong A PharmTech Co Ltd Announces Start of Phase III Trials for Udenafil Its New Erectile Dysfunction Drug Under Development 5977 1Dong A PharmTech Co Ltd Announces Start of Phase III Trials for Udenafil Its New Erectile Dysfunction Drug Under Development 5977 2Company Appoints New SVP Marketing for PBM Business 5974 1Company Appoints New SVP Marketing for PBM Business 5974 2| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |